Researchers from the University of Michigan have developed a way of detecting circulating tumor cells in the bloodstream of pancreatic cancer and lung cancer patients. The study is published in ...

PHC Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura; hereafter referred to as "PHC"), a subsidiary ...

In prostate cancer, reliable markers of disease status are important for selecting and monitoring treatment. Two recent studies have shown that increased levels of circulating cells predict worse ...